nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxcarbazepine—CYP3A5—Vincristine—muscle cancer	0.135	0.273	CbGbCtD
Oxcarbazepine—CYP3A5—Etoposide—muscle cancer	0.124	0.25	CbGbCtD
Oxcarbazepine—ALB—Methotrexate—muscle cancer	0.102	0.206	CbGbCtD
Oxcarbazepine—CYP3A4—Vincristine—muscle cancer	0.0527	0.107	CbGbCtD
Oxcarbazepine—CYP3A4—Etoposide—muscle cancer	0.0483	0.0976	CbGbCtD
Oxcarbazepine—CYP3A4—Doxorubicin—muscle cancer	0.0329	0.0666	CbGbCtD
Oxcarbazepine—Nepafenac—PTGS2—muscle cancer	0.00253	0.267	CrCbGaD
Oxcarbazepine—Magnesium salicylate—PTGS2—muscle cancer	0.00247	0.261	CrCbGaD
Oxcarbazepine—Piroxicam—PTGS2—muscle cancer	0.00237	0.25	CrCbGaD
Oxcarbazepine—Salsalate—PTGS2—muscle cancer	0.0021	0.222	CrCbGaD
Oxcarbazepine—Pain—Vincristine—muscle cancer	0.000815	0.00164	CcSEcCtD
Oxcarbazepine—Pain in extremity—Doxorubicin—muscle cancer	0.000815	0.00164	CcSEcCtD
Oxcarbazepine—Diplopia—Doxorubicin—muscle cancer	0.000815	0.00164	CcSEcCtD
Oxcarbazepine—Asthma—Methotrexate—muscle cancer	0.000813	0.00164	CcSEcCtD
Oxcarbazepine—Chest pain—Etoposide—muscle cancer	0.000806	0.00162	CcSEcCtD
Oxcarbazepine—Eosinophilia—Methotrexate—muscle cancer	0.000805	0.00162	CcSEcCtD
Oxcarbazepine—Affect lability—Doxorubicin—muscle cancer	0.000802	0.00162	CcSEcCtD
Oxcarbazepine—Migraine—Doxorubicin—muscle cancer	0.000802	0.00162	CcSEcCtD
Oxcarbazepine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.0008	0.00161	CcSEcCtD
Oxcarbazepine—Pancreatitis—Methotrexate—muscle cancer	0.000797	0.00161	CcSEcCtD
Oxcarbazepine—Discomfort—Etoposide—muscle cancer	0.000796	0.0016	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Dactinomycin—muscle cancer	0.000786	0.00158	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Vincristine—muscle cancer	0.000779	0.00157	CcSEcCtD
Oxcarbazepine—Confusional state—Etoposide—muscle cancer	0.000779	0.00157	CcSEcCtD
Oxcarbazepine—Pancytopenia—Methotrexate—muscle cancer	0.000772	0.00156	CcSEcCtD
Oxcarbazepine—Anaphylactic shock—Etoposide—muscle cancer	0.000772	0.00156	CcSEcCtD
Oxcarbazepine—Mood swings—Doxorubicin—muscle cancer	0.000772	0.00156	CcSEcCtD
Oxcarbazepine—Infection—Etoposide—muscle cancer	0.000767	0.00155	CcSEcCtD
Oxcarbazepine—Ataxia—Doxorubicin—muscle cancer	0.000766	0.00154	CcSEcCtD
Oxcarbazepine—Asthenia—Dactinomycin—muscle cancer	0.000765	0.00154	CcSEcCtD
Oxcarbazepine—Dysuria—Methotrexate—muscle cancer	0.000761	0.00153	CcSEcCtD
Oxcarbazepine—Neutropenia—Methotrexate—muscle cancer	0.000761	0.00153	CcSEcCtD
Oxcarbazepine—Thrombocytopenia—Etoposide—muscle cancer	0.000756	0.00152	CcSEcCtD
Oxcarbazepine—Upper respiratory tract infection—Methotrexate—muscle cancer	0.000756	0.00152	CcSEcCtD
Oxcarbazepine—Tachycardia—Etoposide—muscle cancer	0.000754	0.00152	CcSEcCtD
Oxcarbazepine—Abdominal pain—Vincristine—muscle cancer	0.000754	0.00152	CcSEcCtD
Oxcarbazepine—Body temperature increased—Vincristine—muscle cancer	0.000754	0.00152	CcSEcCtD
Oxcarbazepine—Liver function test abnormal—Doxorubicin—muscle cancer	0.000752	0.00152	CcSEcCtD
Oxcarbazepine—Skin disorder—Etoposide—muscle cancer	0.00075	0.00151	CcSEcCtD
Oxcarbazepine—Hyperhidrosis—Etoposide—muscle cancer	0.000747	0.0015	CcSEcCtD
Oxcarbazepine—Orthostatic hypotension—Doxorubicin—muscle cancer	0.000744	0.0015	CcSEcCtD
Oxcarbazepine—Abdominal pain upper—Doxorubicin—muscle cancer	0.000744	0.0015	CcSEcCtD
Oxcarbazepine—Photosensitivity reaction—Methotrexate—muscle cancer	0.000742	0.0015	CcSEcCtD
Oxcarbazepine—Hypokalaemia—Doxorubicin—muscle cancer	0.000742	0.00149	CcSEcCtD
Oxcarbazepine—Anorexia—Etoposide—muscle cancer	0.000736	0.00148	CcSEcCtD
Oxcarbazepine—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.000734	0.00148	CcSEcCtD
Oxcarbazepine—Diarrhoea—Dactinomycin—muscle cancer	0.00073	0.00147	CcSEcCtD
Oxcarbazepine—Pneumonia—Methotrexate—muscle cancer	0.000729	0.00147	CcSEcCtD
Oxcarbazepine—Nasopharyngitis—Doxorubicin—muscle cancer	0.000729	0.00147	CcSEcCtD
Oxcarbazepine—Infestation NOS—Methotrexate—muscle cancer	0.000725	0.00146	CcSEcCtD
Oxcarbazepine—Infestation—Methotrexate—muscle cancer	0.000725	0.00146	CcSEcCtD
Oxcarbazepine—Hypotension—Etoposide—muscle cancer	0.000722	0.00145	CcSEcCtD
Oxcarbazepine—Gastritis—Doxorubicin—muscle cancer	0.000721	0.00145	CcSEcCtD
Oxcarbazepine—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000719	0.00145	CcSEcCtD
Oxcarbazepine—Muscular weakness—Doxorubicin—muscle cancer	0.000719	0.00145	CcSEcCtD
Oxcarbazepine—Renal failure—Methotrexate—muscle cancer	0.000713	0.00144	CcSEcCtD
Oxcarbazepine—Stomatitis—Methotrexate—muscle cancer	0.000707	0.00142	CcSEcCtD
Oxcarbazepine—Dysphagia—Doxorubicin—muscle cancer	0.000704	0.00142	CcSEcCtD
Oxcarbazepine—Asthma—Doxorubicin—muscle cancer	0.000704	0.00142	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Vincristine—muscle cancer	0.000702	0.00142	CcSEcCtD
Oxcarbazepine—Eosinophilia—Doxorubicin—muscle cancer	0.000697	0.00141	CcSEcCtD
Oxcarbazepine—Haematuria—Methotrexate—muscle cancer	0.000691	0.00139	CcSEcCtD
Oxcarbazepine—Pancreatitis—Doxorubicin—muscle cancer	0.000691	0.00139	CcSEcCtD
Oxcarbazepine—Dyspnoea—Etoposide—muscle cancer	0.000688	0.00139	CcSEcCtD
Oxcarbazepine—Somnolence—Etoposide—muscle cancer	0.000686	0.00138	CcSEcCtD
Oxcarbazepine—Hepatobiliary disease—Methotrexate—muscle cancer	0.000686	0.00138	CcSEcCtD
Oxcarbazepine—Epistaxis—Methotrexate—muscle cancer	0.000684	0.00138	CcSEcCtD
Oxcarbazepine—Asthenia—Vincristine—muscle cancer	0.000684	0.00138	CcSEcCtD
Oxcarbazepine—Vomiting—Dactinomycin—muscle cancer	0.000678	0.00137	CcSEcCtD
Oxcarbazepine—Bronchitis—Doxorubicin—muscle cancer	0.000677	0.00137	CcSEcCtD
Oxcarbazepine—Agranulocytosis—Methotrexate—muscle cancer	0.000677	0.00136	CcSEcCtD
Oxcarbazepine—Rash—Dactinomycin—muscle cancer	0.000673	0.00136	CcSEcCtD
Oxcarbazepine—Decreased appetite—Etoposide—muscle cancer	0.000671	0.00135	CcSEcCtD
Oxcarbazepine—Pancytopenia—Doxorubicin—muscle cancer	0.000669	0.00135	CcSEcCtD
Oxcarbazepine—Gastrointestinal disorder—Etoposide—muscle cancer	0.000667	0.00134	CcSEcCtD
Oxcarbazepine—Fatigue—Etoposide—muscle cancer	0.000666	0.00134	CcSEcCtD
Oxcarbazepine—Pain—Etoposide—muscle cancer	0.00066	0.00133	CcSEcCtD
Oxcarbazepine—Constipation—Etoposide—muscle cancer	0.00066	0.00133	CcSEcCtD
Oxcarbazepine—Neutropenia—Doxorubicin—muscle cancer	0.000659	0.00133	CcSEcCtD
Oxcarbazepine—Dysuria—Doxorubicin—muscle cancer	0.000659	0.00133	CcSEcCtD
Oxcarbazepine—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.000655	0.00132	CcSEcCtD
Oxcarbazepine—Diarrhoea—Vincristine—muscle cancer	0.000652	0.00131	CcSEcCtD
Oxcarbazepine—Hepatitis—Methotrexate—muscle cancer	0.000651	0.00131	CcSEcCtD
Oxcarbazepine—Pollakiuria—Doxorubicin—muscle cancer	0.000651	0.00131	CcSEcCtD
Oxcarbazepine—Pharyngitis—Methotrexate—muscle cancer	0.000646	0.0013	CcSEcCtD
Oxcarbazepine—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000643	0.0013	CcSEcCtD
Oxcarbazepine—Weight increased—Doxorubicin—muscle cancer	0.000641	0.00129	CcSEcCtD
Oxcarbazepine—Weight decreased—Doxorubicin—muscle cancer	0.000637	0.00128	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Etoposide—muscle cancer	0.000636	0.00128	CcSEcCtD
Oxcarbazepine—Hyperglycaemia—Doxorubicin—muscle cancer	0.000635	0.00128	CcSEcCtD
Oxcarbazepine—Nausea—Dactinomycin—muscle cancer	0.000634	0.00128	CcSEcCtD
Oxcarbazepine—Pneumonia—Doxorubicin—muscle cancer	0.000632	0.00127	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Etoposide—muscle cancer	0.000631	0.00127	CcSEcCtD
Oxcarbazepine—Dizziness—Vincristine—muscle cancer	0.00063	0.00127	CcSEcCtD
Oxcarbazepine—Infestation—Doxorubicin—muscle cancer	0.000628	0.00127	CcSEcCtD
Oxcarbazepine—Infestation NOS—Doxorubicin—muscle cancer	0.000628	0.00127	CcSEcCtD
Oxcarbazepine—Visual impairment—Methotrexate—muscle cancer	0.000627	0.00126	CcSEcCtD
Oxcarbazepine—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000623	0.00125	CcSEcCtD
Oxcarbazepine—Renal failure—Doxorubicin—muscle cancer	0.000617	0.00124	CcSEcCtD
Oxcarbazepine—Erythema multiforme—Methotrexate—muscle cancer	0.000616	0.00124	CcSEcCtD
Oxcarbazepine—Urticaria—Etoposide—muscle cancer	0.000613	0.00124	CcSEcCtD
Oxcarbazepine—Stomatitis—Doxorubicin—muscle cancer	0.000612	0.00123	CcSEcCtD
Oxcarbazepine—Abdominal pain—Etoposide—muscle cancer	0.00061	0.00123	CcSEcCtD
Oxcarbazepine—Body temperature increased—Etoposide—muscle cancer	0.00061	0.00123	CcSEcCtD
Oxcarbazepine—Urinary tract infection—Doxorubicin—muscle cancer	0.00061	0.00123	CcSEcCtD
Oxcarbazepine—Eye disorder—Methotrexate—muscle cancer	0.000608	0.00123	CcSEcCtD
Oxcarbazepine—Tinnitus—Methotrexate—muscle cancer	0.000607	0.00122	CcSEcCtD
Oxcarbazepine—Vomiting—Vincristine—muscle cancer	0.000606	0.00122	CcSEcCtD
Oxcarbazepine—Cardiac disorder—Methotrexate—muscle cancer	0.000604	0.00122	CcSEcCtD
Oxcarbazepine—Rash—Vincristine—muscle cancer	0.000601	0.00121	CcSEcCtD
Oxcarbazepine—Dermatitis—Vincristine—muscle cancer	0.0006	0.00121	CcSEcCtD
Oxcarbazepine—Haematuria—Doxorubicin—muscle cancer	0.000599	0.00121	CcSEcCtD
Oxcarbazepine—Headache—Vincristine—muscle cancer	0.000597	0.0012	CcSEcCtD
Oxcarbazepine—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000594	0.0012	CcSEcCtD
Oxcarbazepine—Epistaxis—Doxorubicin—muscle cancer	0.000592	0.00119	CcSEcCtD
Oxcarbazepine—Angiopathy—Methotrexate—muscle cancer	0.000591	0.00119	CcSEcCtD
Oxcarbazepine—Sinusitis—Doxorubicin—muscle cancer	0.000589	0.00119	CcSEcCtD
Oxcarbazepine—Immune system disorder—Methotrexate—muscle cancer	0.000588	0.00119	CcSEcCtD
Oxcarbazepine—Agranulocytosis—Doxorubicin—muscle cancer	0.000586	0.00118	CcSEcCtD
Oxcarbazepine—Chills—Methotrexate—muscle cancer	0.000584	0.00118	CcSEcCtD
Oxcarbazepine—Alopecia—Methotrexate—muscle cancer	0.000575	0.00116	CcSEcCtD
Oxcarbazepine—Bradycardia—Doxorubicin—muscle cancer	0.000574	0.00116	CcSEcCtD
Oxcarbazepine—Mental disorder—Methotrexate—muscle cancer	0.00057	0.00115	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Etoposide—muscle cancer	0.000569	0.00115	CcSEcCtD
Oxcarbazepine—Malnutrition—Methotrexate—muscle cancer	0.000567	0.00114	CcSEcCtD
Oxcarbazepine—Nausea—Vincristine—muscle cancer	0.000566	0.00114	CcSEcCtD
Oxcarbazepine—Rhinitis—Doxorubicin—muscle cancer	0.000565	0.00114	CcSEcCtD
Oxcarbazepine—Hepatitis—Doxorubicin—muscle cancer	0.000564	0.00114	CcSEcCtD
Oxcarbazepine—Hypoaesthesia—Doxorubicin—muscle cancer	0.000561	0.00113	CcSEcCtD
Oxcarbazepine—Pharyngitis—Doxorubicin—muscle cancer	0.00056	0.00113	CcSEcCtD
Oxcarbazepine—Oedema peripheral—Doxorubicin—muscle cancer	0.000555	0.00112	CcSEcCtD
Oxcarbazepine—Dysgeusia—Methotrexate—muscle cancer	0.000555	0.00112	CcSEcCtD
Oxcarbazepine—Asthenia—Etoposide—muscle cancer	0.000554	0.00112	CcSEcCtD
Oxcarbazepine—Back pain—Methotrexate—muscle cancer	0.000548	0.0011	CcSEcCtD
Oxcarbazepine—Pruritus—Etoposide—muscle cancer	0.000546	0.0011	CcSEcCtD
Oxcarbazepine—Visual impairment—Doxorubicin—muscle cancer	0.000543	0.0011	CcSEcCtD
Oxcarbazepine—Vision blurred—Methotrexate—muscle cancer	0.000534	0.00108	CcSEcCtD
Oxcarbazepine—Erythema multiforme—Doxorubicin—muscle cancer	0.000533	0.00107	CcSEcCtD
Oxcarbazepine—Diarrhoea—Etoposide—muscle cancer	0.000528	0.00106	CcSEcCtD
Oxcarbazepine—Eye disorder—Doxorubicin—muscle cancer	0.000527	0.00106	CcSEcCtD
Oxcarbazepine—Ill-defined disorder—Methotrexate—muscle cancer	0.000526	0.00106	CcSEcCtD
Oxcarbazepine—Tinnitus—Doxorubicin—muscle cancer	0.000526	0.00106	CcSEcCtD
Oxcarbazepine—Cardiac disorder—Doxorubicin—muscle cancer	0.000523	0.00105	CcSEcCtD
Oxcarbazepine—Flushing—Doxorubicin—muscle cancer	0.000523	0.00105	CcSEcCtD
Oxcarbazepine—Angiopathy—Doxorubicin—muscle cancer	0.000511	0.00103	CcSEcCtD
Oxcarbazepine—Malaise—Methotrexate—muscle cancer	0.000511	0.00103	CcSEcCtD
Oxcarbazepine—Dizziness—Etoposide—muscle cancer	0.000511	0.00103	CcSEcCtD
Oxcarbazepine—Immune system disorder—Doxorubicin—muscle cancer	0.000509	0.00103	CcSEcCtD
Oxcarbazepine—Vertigo—Methotrexate—muscle cancer	0.000509	0.00103	CcSEcCtD
Oxcarbazepine—Leukopenia—Methotrexate—muscle cancer	0.000507	0.00102	CcSEcCtD
Oxcarbazepine—Chills—Doxorubicin—muscle cancer	0.000506	0.00102	CcSEcCtD
Oxcarbazepine—Arrhythmia—Doxorubicin—muscle cancer	0.000504	0.00102	CcSEcCtD
Oxcarbazepine—Alopecia—Doxorubicin—muscle cancer	0.000498	0.001	CcSEcCtD
Oxcarbazepine—Cough—Methotrexate—muscle cancer	0.000495	0.000997	CcSEcCtD
Oxcarbazepine—Mental disorder—Doxorubicin—muscle cancer	0.000494	0.000995	CcSEcCtD
Oxcarbazepine—Convulsion—Methotrexate—muscle cancer	0.000491	0.00099	CcSEcCtD
Oxcarbazepine—Vomiting—Etoposide—muscle cancer	0.000491	0.00099	CcSEcCtD
Oxcarbazepine—Malnutrition—Doxorubicin—muscle cancer	0.000491	0.000989	CcSEcCtD
Oxcarbazepine—Rash—Etoposide—muscle cancer	0.000487	0.000981	CcSEcCtD
Oxcarbazepine—Dermatitis—Etoposide—muscle cancer	0.000486	0.00098	CcSEcCtD
Oxcarbazepine—Headache—Etoposide—muscle cancer	0.000484	0.000975	CcSEcCtD
Oxcarbazepine—Flatulence—Doxorubicin—muscle cancer	0.000484	0.000975	CcSEcCtD
Oxcarbazepine—Myalgia—Methotrexate—muscle cancer	0.000482	0.000973	CcSEcCtD
Oxcarbazepine—Chest pain—Methotrexate—muscle cancer	0.000482	0.000973	CcSEcCtD
Oxcarbazepine—Arthralgia—Methotrexate—muscle cancer	0.000482	0.000973	CcSEcCtD
Oxcarbazepine—Tension—Doxorubicin—muscle cancer	0.000482	0.000971	CcSEcCtD
Oxcarbazepine—Dysgeusia—Doxorubicin—muscle cancer	0.000481	0.000969	CcSEcCtD
Oxcarbazepine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000479	0.000966	CcSEcCtD
Oxcarbazepine—Discomfort—Methotrexate—muscle cancer	0.000477	0.000961	CcSEcCtD
Oxcarbazepine—Nervousness—Doxorubicin—muscle cancer	0.000477	0.000961	CcSEcCtD
Oxcarbazepine—Back pain—Doxorubicin—muscle cancer	0.000475	0.000957	CcSEcCtD
Oxcarbazepine—Confusional state—Methotrexate—muscle cancer	0.000466	0.00094	CcSEcCtD
Oxcarbazepine—Anaphylactic shock—Methotrexate—muscle cancer	0.000463	0.000932	CcSEcCtD
Oxcarbazepine—Vision blurred—Doxorubicin—muscle cancer	0.000462	0.000932	CcSEcCtD
Oxcarbazepine—Infection—Methotrexate—muscle cancer	0.00046	0.000926	CcSEcCtD
Oxcarbazepine—Nausea—Etoposide—muscle cancer	0.000459	0.000925	CcSEcCtD
Oxcarbazepine—Ill-defined disorder—Doxorubicin—muscle cancer	0.000455	0.000918	CcSEcCtD
Oxcarbazepine—Nervous system disorder—Methotrexate—muscle cancer	0.000454	0.000914	CcSEcCtD
Oxcarbazepine—Thrombocytopenia—Methotrexate—muscle cancer	0.000453	0.000913	CcSEcCtD
Oxcarbazepine—Agitation—Doxorubicin—muscle cancer	0.000451	0.000909	CcSEcCtD
Oxcarbazepine—Skin disorder—Methotrexate—muscle cancer	0.000449	0.000906	CcSEcCtD
Oxcarbazepine—Hyperhidrosis—Methotrexate—muscle cancer	0.000447	0.000901	CcSEcCtD
Oxcarbazepine—Malaise—Doxorubicin—muscle cancer	0.000443	0.000892	CcSEcCtD
Oxcarbazepine—Vertigo—Doxorubicin—muscle cancer	0.000441	0.000889	CcSEcCtD
Oxcarbazepine—Anorexia—Methotrexate—muscle cancer	0.000441	0.000889	CcSEcCtD
Oxcarbazepine—Syncope—Doxorubicin—muscle cancer	0.00044	0.000887	CcSEcCtD
Oxcarbazepine—Leukopenia—Doxorubicin—muscle cancer	0.000439	0.000885	CcSEcCtD
Oxcarbazepine—Palpitations—Doxorubicin—muscle cancer	0.000434	0.000874	CcSEcCtD
Oxcarbazepine—Hypotension—Methotrexate—muscle cancer	0.000432	0.000871	CcSEcCtD
Oxcarbazepine—Loss of consciousness—Doxorubicin—muscle cancer	0.000431	0.000869	CcSEcCtD
Oxcarbazepine—Cough—Doxorubicin—muscle cancer	0.000428	0.000863	CcSEcCtD
Oxcarbazepine—Convulsion—Doxorubicin—muscle cancer	0.000425	0.000857	CcSEcCtD
Oxcarbazepine—Hypertension—Doxorubicin—muscle cancer	0.000424	0.000854	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000421	0.000849	CcSEcCtD
Oxcarbazepine—Insomnia—Methotrexate—muscle cancer	0.000418	0.000843	CcSEcCtD
Oxcarbazepine—Chest pain—Doxorubicin—muscle cancer	0.000418	0.000842	CcSEcCtD
Oxcarbazepine—Arthralgia—Doxorubicin—muscle cancer	0.000418	0.000842	CcSEcCtD
Oxcarbazepine—Myalgia—Doxorubicin—muscle cancer	0.000418	0.000842	CcSEcCtD
Oxcarbazepine—Anxiety—Doxorubicin—muscle cancer	0.000416	0.000839	CcSEcCtD
Oxcarbazepine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000415	0.000836	CcSEcCtD
Oxcarbazepine—Discomfort—Doxorubicin—muscle cancer	0.000413	0.000832	CcSEcCtD
Oxcarbazepine—Dyspnoea—Methotrexate—muscle cancer	0.000412	0.000831	CcSEcCtD
Oxcarbazepine—Somnolence—Methotrexate—muscle cancer	0.000411	0.000829	CcSEcCtD
Oxcarbazepine—Dry mouth—Doxorubicin—muscle cancer	0.000409	0.000824	CcSEcCtD
Oxcarbazepine—Dyspepsia—Methotrexate—muscle cancer	0.000407	0.000821	CcSEcCtD
Oxcarbazepine—Confusional state—Doxorubicin—muscle cancer	0.000404	0.000814	CcSEcCtD
Oxcarbazepine—Decreased appetite—Methotrexate—muscle cancer	0.000402	0.00081	CcSEcCtD
Oxcarbazepine—Anaphylactic shock—Doxorubicin—muscle cancer	0.000401	0.000807	CcSEcCtD
Oxcarbazepine—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000399	0.000805	CcSEcCtD
Oxcarbazepine—Fatigue—Methotrexate—muscle cancer	0.000399	0.000804	CcSEcCtD
Oxcarbazepine—Infection—Doxorubicin—muscle cancer	0.000398	0.000802	CcSEcCtD
Oxcarbazepine—Pain—Methotrexate—muscle cancer	0.000396	0.000797	CcSEcCtD
Oxcarbazepine—Shock—Doxorubicin—muscle cancer	0.000394	0.000794	CcSEcCtD
Oxcarbazepine—Nervous system disorder—Doxorubicin—muscle cancer	0.000393	0.000792	CcSEcCtD
Oxcarbazepine—Thrombocytopenia—Doxorubicin—muscle cancer	0.000392	0.00079	CcSEcCtD
Oxcarbazepine—Tachycardia—Doxorubicin—muscle cancer	0.000391	0.000788	CcSEcCtD
Oxcarbazepine—Skin disorder—Doxorubicin—muscle cancer	0.000389	0.000784	CcSEcCtD
Oxcarbazepine—Hyperhidrosis—Doxorubicin—muscle cancer	0.000387	0.00078	CcSEcCtD
Oxcarbazepine—Anorexia—Doxorubicin—muscle cancer	0.000382	0.00077	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Methotrexate—muscle cancer	0.000381	0.000768	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Methotrexate—muscle cancer	0.000378	0.000762	CcSEcCtD
Oxcarbazepine—Hypotension—Doxorubicin—muscle cancer	0.000374	0.000754	CcSEcCtD
Oxcarbazepine—Urticaria—Methotrexate—muscle cancer	0.000367	0.000741	CcSEcCtD
Oxcarbazepine—Body temperature increased—Methotrexate—muscle cancer	0.000366	0.000737	CcSEcCtD
Oxcarbazepine—Abdominal pain—Methotrexate—muscle cancer	0.000366	0.000737	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000365	0.000735	CcSEcCtD
Oxcarbazepine—Insomnia—Doxorubicin—muscle cancer	0.000362	0.00073	CcSEcCtD
Oxcarbazepine—Dyspnoea—Doxorubicin—muscle cancer	0.000357	0.00072	CcSEcCtD
Oxcarbazepine—Somnolence—Doxorubicin—muscle cancer	0.000356	0.000718	CcSEcCtD
Oxcarbazepine—Dyspepsia—Doxorubicin—muscle cancer	0.000353	0.000711	CcSEcCtD
Oxcarbazepine—Decreased appetite—Doxorubicin—muscle cancer	0.000348	0.000702	CcSEcCtD
Oxcarbazepine—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000346	0.000697	CcSEcCtD
Oxcarbazepine—Fatigue—Doxorubicin—muscle cancer	0.000345	0.000696	CcSEcCtD
Oxcarbazepine—Constipation—Doxorubicin—muscle cancer	0.000342	0.00069	CcSEcCtD
Oxcarbazepine—Pain—Doxorubicin—muscle cancer	0.000342	0.00069	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Methotrexate—muscle cancer	0.000341	0.000687	CcSEcCtD
Oxcarbazepine—Asthenia—Methotrexate—muscle cancer	0.000332	0.000669	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Doxorubicin—muscle cancer	0.00033	0.000665	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000328	0.00066	CcSEcCtD
Oxcarbazepine—Pruritus—Methotrexate—muscle cancer	0.000327	0.00066	CcSEcCtD
Oxcarbazepine—Urticaria—Doxorubicin—muscle cancer	0.000318	0.000641	CcSEcCtD
Oxcarbazepine—Abdominal pain—Doxorubicin—muscle cancer	0.000317	0.000638	CcSEcCtD
Oxcarbazepine—Body temperature increased—Doxorubicin—muscle cancer	0.000317	0.000638	CcSEcCtD
Oxcarbazepine—Diarrhoea—Methotrexate—muscle cancer	0.000316	0.000638	CcSEcCtD
Oxcarbazepine—Dizziness—Methotrexate—muscle cancer	0.000306	0.000617	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Doxorubicin—muscle cancer	0.000295	0.000595	CcSEcCtD
Oxcarbazepine—Vomiting—Methotrexate—muscle cancer	0.000294	0.000593	CcSEcCtD
Oxcarbazepine—Rash—Methotrexate—muscle cancer	0.000292	0.000588	CcSEcCtD
Oxcarbazepine—Dermatitis—Methotrexate—muscle cancer	0.000291	0.000587	CcSEcCtD
Oxcarbazepine—Headache—Methotrexate—muscle cancer	0.00029	0.000584	CcSEcCtD
Oxcarbazepine—Asthenia—Doxorubicin—muscle cancer	0.000287	0.000579	CcSEcCtD
Oxcarbazepine—Pruritus—Doxorubicin—muscle cancer	0.000283	0.000571	CcSEcCtD
Oxcarbazepine—Nausea—Methotrexate—muscle cancer	0.000275	0.000554	CcSEcCtD
Oxcarbazepine—Diarrhoea—Doxorubicin—muscle cancer	0.000274	0.000552	CcSEcCtD
Oxcarbazepine—Dizziness—Doxorubicin—muscle cancer	0.000265	0.000534	CcSEcCtD
Oxcarbazepine—Vomiting—Doxorubicin—muscle cancer	0.000255	0.000513	CcSEcCtD
Oxcarbazepine—Rash—Doxorubicin—muscle cancer	0.000253	0.000509	CcSEcCtD
Oxcarbazepine—Dermatitis—Doxorubicin—muscle cancer	0.000252	0.000509	CcSEcCtD
Oxcarbazepine—Headache—Doxorubicin—muscle cancer	0.000251	0.000506	CcSEcCtD
Oxcarbazepine—Nausea—Doxorubicin—muscle cancer	0.000238	0.00048	CcSEcCtD
